Mainolfi Nello

Chief Executive Officer, DirectorKymera Therapeutics, Inc. (KYMR) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9.2M
Net Open-Market Flow
-$9.2M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)80K$2.08$166K747K
Jul 1, 2026Sell(S)2K$112.80$212K745K
Jul 1, 2026Sell(S)7K$113.98$755K738K
Jul 1, 2026Sell(S)24K$114.96$2.8M714K
Jul 1, 2026Sell(S)44K$115.69$5.1M670K
Jul 1, 2026Sell(S)3K$116.56$389K667K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)80K$0136K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-295088) within minutes of acceptance. Every field above traces to the original document. Verify it directly: